CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
5Y CAGR-33.8%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
-33.8%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
202535.15%
2024-2.61%
2023-5.32%
2022-143.02%
2021-201.67%
2020276.58%
2019-126.13%
2018-36.23%
2017228.33%
2016-58.61%